Pulmonx Corporation (NASDAQ:LUNG) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Laine Morgan - Investor Relations Glen French - President and Chief Executive Officer Derrick Sung - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Jason Bednar - Piper Sandler Operator Good afternoon and welcome to Pulmonx Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answe ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | ...

Pulmonx Corporation (NASDAQ:LUNG) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group Glen French - President and Chief Executive Officer Derrick Sung - Chief Financial Officer Conference Call Participants Cecilia Furlong - Morgan Stanley Travis Steed - BofA Securities David Ko - Canaccord Genuity Larry Biegelsen - Wells Fargo Joseph Downing - PSC Joanne Wuensch - Citi Operator Good afternoon, and welcome to Pulmonx Second Quarter 2022 Earnings Conf ...

NASDAQ: LUNG May 2022 © 2022 Pulmonx Corporation1 Forward Looking Statement This presentation and certain statements made during this presentation contain forward-looking statements that involve risks and uncertainties. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strat ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 77-0424412 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 700 Chesapeake Drive Redwood City, California 94063 1-650-364-0400 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) For the quarte ...

Pulmonx Corporation (NASDAQ:LUNG) Q1 2022 Results Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Brian Johnston - VP, Investor Relations, Gilmartin Group Glendon French - President & Chief Executive Officer Derrick Sung - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Cecilia Furlong - Morgan Stanley Operator Thank you for standing by, and welcome to the Pulmonx Q1 2022 Earnings Conference Call. At this time, all participants are in a listen-only. A ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-39562 PULMONX CORPORATION (Exact name of registrant as specified in its charter) Delaware 77-0424412 (State or other jurisdiction of incorporation or organizati ...

NASDAQ: LUNG February 2022 © 2022 Pulmonx Corporation1 Forward Looking Statement This presentation and certain statements made during this presentation contain forward-looking statements that involve risks and uncertainties. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business ...

Pulmonx Corporation (NASDAQ:LUNG) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Glen French - President & Chief Executive Officer Derrick Sung - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Rick Wise - Stifel Operator Ladies and gentlemen, thank you for standing by and welcome to the Pulmonx Quarter Four 2021 Earnings Conference Call. At this time, all participants are in a listen-only. Later, we will conduct a question-and-answer ses ...

NASDAQ: LUNG January 2022 © 2022 Pulmonx Corporation1 Forward Looking Statement This presentation and certain statements made during this presentation contain forward-looking statements that involve risks and uncertainties. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business s ...